|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/06 | |
| A61K 38/48 | |||
| A61K 38/55 | |||
| A61K 38/57 | |||
| A61K 39/395 | |||
| A61K 47/50 | |||
| C07K 14/81 | |||
| C07K 16/36 | |||
| C07K 16/40 | |||
| A61P 25/00 | |||
| A61P 37/00 | |||
| A61K 38/17 |
| (11) | Number of the document | 2809336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13701651.5 |
| Date of filing the European patent application | 2013-01-31 | |
| (97) | Date of publication of the European application | 2014-12-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/051832 |
| Date | 2013-01-31 |
| (87) | Number | WO 2013/113774 |
| Date | 2013-08-08 |
| (30) | Number | Date | Country code |
| 12153341 | 2012-01-31 | EP | |
| 201261592652 P | 2012-01-31 | US |
| (72) |
MEUTH, Sven, DE
GOEBEL, Kerstin, DE
KLEINSCHNITZ, Christoph, DE
MCKENZIE, Brent, US
NOLTE, Marc, DE
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
Westfälische Wilhelms-Universität Münster, Schlossplatz 2, 48149 Münster, DE CSL Limited, 45 Poplar Road, Parkville VIC 3052, AU Julius-Maximilians-Universitaet Wuerzburg, Sanderring 2, 97070 Wuerzburg, DE |
| (54) | FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS |
| FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS |